Critical review of cancer risk associated with angiotensin receptor blocker therapy


The role of drugs in new cancer occurrence and cancer-related death is a major concern. Recently, a meta-analysis raised the possibility that angiotensin receptor blockers (ARBs) might have an adverse effect on patients. This generated a significant debate until the publication of two further meta-analyses, neither of which demonstrated an increased risk of… (More)
DOI: 10.2147/VHRM.S13552

2 Figures and Tables